Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Alteration With Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy (METAL-HCM Study)

NCT00500552 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT00500552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00500552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Alteration With Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy (METAL-HCM Study)
Lead sponsor
University Hospital Birmingham
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
August 31, 2010
Enrollment
44 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy